Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity

被引:22
作者
Osada, Kenichi [1 ]
Oka, Hiroshi [2 ]
Isomura, Tatsuya [3 ]
Nakamura, Ikuro [4 ]
Tominaga, Keiichiro
Takahashi, Shinobu [5 ]
Kojima, Ayako [6 ]
Nishioka, Kusuki [2 ]
机构
[1] St Marianna Univ, Sch Med, Dept Neuropsychiat, Miyamae Ku, Kanagawa 2168511, Japan
[2] St Marianna Univ, Sch Med, Inst Med Sci, Kanagawa 2168511, Japan
[3] Clin Study Support Inc, Aichi, Japan
[4] Argenes Inc, Tokyo, Japan
[5] Kasumigaseki Urban Clin, Tokyo, Japan
[6] Gakushuin Univ, Grad Sch Humanities, Tokyo 171, Japan
关键词
Fibromyalgia Impact Questionnaire; Japanese version; psychometric assessment; reliability; validity; VALIDATION; PAIN;
D O I
10.1111/j.1756-185X.2010.01585.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To perform a psychometric assessment of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ). Methods: Data for the psychometric assessment were collected from Japanese fibromyalgia (FM) patients who visited a clinic. Analyses were performed to examine the reliability and validity of the JFIQ. Results: A total of 56 patients were included in the analysis. There was no remarkable floor or ceiling effect for the JFIQ item or total scores. In the analysis of reproducibility, the interclass correlation coefficients of each item score and total score ranged from 0.61 to 0.95. Cronbach's alpha coefficient was 0.92. For the concurrent validity, the total score and most of the item scores correlated to every domain of Short Form-36 or Beck Depression Inventory-II to a moderate or great extent. The results of the known-group comparisons indicated that the total score tended to increase with the increase in severity of FM and pain (P-values for trend < 0.05). Conclusion: This psychometric assessment demonstrated good reliability and validity of the JFIQ for use with Japanese FM patients. In the future, we expect that this questionnaire will be used in clinical studies and medical practice, and will be beneficial in the development of new therapies as well as for the comprehensive evaluation of patients' conditions in Japan.
引用
收藏
页码:74 / 80
页数:7
相关论文
共 24 条
[1]  
ARITA H, 2008, PAIN CLINIC, V29, P115
[2]  
Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154
[3]  
BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728
[4]  
Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
[5]   POPULATION STUDY OF TENDER POINT COUNTS AND PAIN AS EVIDENCE OF FIBROMYALGIA [J].
CROFT, P ;
SCHOLLUM, J ;
SILMAN, A .
BRITISH MEDICAL JOURNAL, 1994, 309 (6956) :696-699
[6]   A WILCOXON-TYPE TEST FOR TREND [J].
CUZICK, J .
STATISTICS IN MEDICINE, 1985, 4 (01) :87-90
[7]   Core outcome measures for chronic pain clinical trials: IMMPACT recommendations [J].
Dworkin, RH ;
Turk, DC ;
Farrar, JT ;
Haythornthwaite, JA ;
Jensen, MP ;
Katz, NP ;
Kerns, RD ;
Stucki, G ;
Allen, RR ;
Bellamy, N ;
Carr, DB ;
Chandler, J ;
Cowan, P ;
Dionne, R ;
Galer, BS ;
Hertz, S ;
Jadad, AR ;
Kramer, LD ;
Manning, DC ;
Martin, S ;
McCormick, CG ;
McDermott, MP ;
McGrath, P ;
Quessy, S ;
Rappaport, BA ;
Robbins, W ;
Robinson, JP ;
Rothman, M ;
Royal, MA ;
Simon, L ;
Stauffer, JW ;
Stein, W ;
Tollett, J ;
Wernicke, J ;
Witter, J .
PAIN, 2005, 113 (1-2) :9-19
[8]  
Fayers P.M., 2007, QUALITY LIFE, V2nd
[9]  
*FIBR INF FDN, 2010, FIBR IMP QUEST FIQ S
[10]   Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan [J].
Fukuhara, S ;
Bito, S ;
Green, J ;
Hsiao, A ;
Kurokawa, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1037-1044